agilon health (AGL) to Release Earnings on Tuesday

agilon health (NYSE:AGL) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. agilon health has set its FY 2024 guidance at EPS.Parties interested in participating in the company’s conference call can do so using this link.

agilon health (NYSE:AGL) last posted its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the company posted ($0.14) EPS. The firm’s revenue for the quarter was up 71.8% compared to the same quarter last year. On average, analysts expect agilon health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

agilon health Price Performance

AGL opened at $4.83 on Friday. The firm’s 50-day simple moving average is $5.41 and its 200-day simple moving average is $9.04. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.51 and a current ratio of 1.51. agilon health has a twelve month low of $4.41 and a twelve month high of $26.75. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of -7.43 and a beta of 0.52.

Analyst Ratings Changes

AGL has been the topic of several analyst reports. Royal Bank of Canada lowered their target price on shares of agilon health from $11.00 to $8.00 and set an “outperform” rating on the stock in a report on Wednesday, February 28th. Jefferies Financial Group reissued a “hold” rating and set a $6.50 price objective (down previously from $25.00) on shares of agilon health in a report on Monday, February 26th. TD Cowen lowered shares of agilon health from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $12.00 to $6.50 in a report on Monday, February 26th. Evercore ISI decreased their price objective on shares of agilon health from $7.00 to $6.00 and set an “in-line” rating on the stock in a report on Wednesday, February 28th. Finally, Barclays assumed coverage on shares of agilon health in a report on Wednesday, March 6th. They set an “underweight” rating and a $5.00 price objective on the stock. One analyst has rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, agilon health presently has an average rating of “Hold” and a consensus price target of $9.32.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.